These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19256030)

  • 21. C-reactive protein gene C1444T polymorphism and risk of recurrent ischemic events in patients with symptomatic intracranial atherostenoses.
    Arenillas JF; Massot A; Alvarez-Sabín J; Fernandez-Cadenas I; del Rio-Espinola A; Chacon P; Quintana M; Molina CA; Rovira A; Montaner J
    Cerebrovasc Dis; 2009; 28(1):95-102. PubMed ID: 19494488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C-reactive protein--should it be used to assess cardiac risk?
    Sitzman K
    AAOHN J; 2005 Apr; 53(4):188. PubMed ID: 15853295
    [No Abstract]   [Full Text] [Related]  

  • 23. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrinogen polymorphisms and disease.
    Laffan MA
    Eur Heart J; 2001 Dec; 22(24):2224-6. PubMed ID: 11728140
    [No Abstract]   [Full Text] [Related]  

  • 25. Linking observational and genetic approaches to determine the role of C-reactive protein in heart disease risk.
    Hingorani AD; Shah T; Casas JP
    Eur Heart J; 2006 Jun; 27(11):1261-3. PubMed ID: 16684780
    [No Abstract]   [Full Text] [Related]  

  • 26. Common polymorphisms in CYP2C9, subclinical atherosclerosis and risk of ischemic vascular disease in 52,000 individuals.
    Kaur-Knudsen D; Bojesen SE; Nordestgaard BG
    Pharmacogenomics J; 2009 Oct; 9(5):327-32. PubMed ID: 19652664
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C-reactive protein 1059G>C genetic polymorphism influences serum C-reactive protein levels after esophagectomy in patients with thoracic esophageal cancer.
    Motoyama S; Miura M; Hinai Y; Maruyama K; Usami S; Nakatsu T; Saito H; Minamiya Y; Suzuki T; Ogawa J
    J Am Coll Surg; 2009 Oct; 209(4):477-83. PubMed ID: 19801321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. C-reactive protein level in dialysis patients: weak genetic influence and nonspecific clinical meaning.
    Tsirpanlis G; Petrihou C; Tsiolaki K; Triantafyllis G; Sakka E; Chatzipanagiotou S
    Am J Kidney Dis; 2007 Jun; 49(6):873. PubMed ID: 17533033
    [No Abstract]   [Full Text] [Related]  

  • 29. [JUPITER can yield paradigmatic shift in the prevention of cardiovascular disease. Focus on inflammation as a risk factor].
    Olsson AG
    Lakartidningen; 2009 May 20-Jun 2; 106(21-22):1471-5. PubMed ID: 19579435
    [No Abstract]   [Full Text] [Related]  

  • 30. Is C-reactive protein an innocent bystander or proatherogenic culprit? The verdict is still out.
    Scirica BM; Morrow DA
    Circulation; 2006 May; 113(17):2128-34; discussion 2151. PubMed ID: 16651484
    [No Abstract]   [Full Text] [Related]  

  • 31. [Pro-inflammatory and anti-inflammatory markers in coronary artery disease and acute ischemic coronary syndrome].
    Fragoso-Lona JM; Ramírez-Bello J; Cruz-Robles D; Pérez-Méndez O; de la Peña A; Vargas-Alarcón G
    Arch Cardiol Mex; 2009; 79(1):54-62. PubMed ID: 19545076
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D; Hoeks SE; Boersma E; Winkel TA; Dunkelgrun M; Flu WJ; Schouten O; Bax JJ; Poldermans D
    Coron Artery Dis; 2009 May; 20(3):219-24. PubMed ID: 19322079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Children genetically predisposed: the added perspectives.
    Kumar B K; Banga U
    Indian Pediatr; 2002 Sep; 39(9):884-5; author reply 886. PubMed ID: 12368545
    [No Abstract]   [Full Text] [Related]  

  • 34. Should physicians measure high-sensitivity C-reactive protein levels to assess coronary heart disease risk?
    Alpert JS
    Am J Med; 2009 May; 122(5):405-6. PubMed ID: 19375543
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of biomarkers and genetics in peripheral arterial disease.
    McDermott MM; Lloyd-Jones DM
    J Am Coll Cardiol; 2009 Sep; 54(14):1228-37. PubMed ID: 19778662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic values of various markers in evaluation of patients with chest pain.
    David DS
    Am J Cardiol; 2009 May; 103(9):1329-30. PubMed ID: 19406283
    [No Abstract]   [Full Text] [Related]  

  • 37. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men.
    García González MJ
    Cardiol J; 2009; 16(4):388; author reply 389. PubMed ID: 19653189
    [No Abstract]   [Full Text] [Related]  

  • 38. Sex hormones as novel risk biomarkers for atherosclerosis in peripheral vascular disease.
    Liu PP; Fukuoka M
    J Am Coll Cardiol; 2007 Sep; 50(11):1077-9. PubMed ID: 17825718
    [No Abstract]   [Full Text] [Related]  

  • 39. Rosuvastatin in patients with elevated C-reactive protein.
    Koller MT; Bucher HC; Steyerberg EW
    N Engl J Med; 2009 Mar; 360(10):1041; author reply 1041-2. PubMed ID: 19271276
    [No Abstract]   [Full Text] [Related]  

  • 40. Biomarkers of premature atherosclerosis.
    Kampoli AM; Tousoulis D; Antoniades C; Siasos G; Stefanadis C
    Trends Mol Med; 2009 Jul; 15(7):323-32. PubMed ID: 19577961
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.